Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Jersey Regenerative Institute specializes in non-surgical regenerative medicine for orthopedic and musculoskeletal conditions. The clinic uses autologous cell-based therapies such as PRP, BMAC, Lipogems adipose tissue injection, prolotherapy with dextrose or ozone, and device-assisted treatments. They actively participate in research and outcomes tracking through DataBiologics but do not develop proprietary drugs or biologics. Their approach focuses on evidence-based recommendations for patients who may be poor surgical candidates or prefer minimally invasive options. Clinical results are tracked longitudinally but formal clinical trial data/publications are limited.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Jersey Regenerative Institute.